Rubedo Life Sciences
Founded 2018 · 32 employees on LinkedIn · 8 known investors
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan. The company applies artificial intelligence and chemistry to drug discovery in the longevity and regenerative medicine space.
Investors · 8
Funding
SEC filings, press & company announcements$40M disclosed across 1 round · 2024
- $40MSeries AApr 2024 · 2 sources
Ahren Innovation Capital (lead), Khosla Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Rubedo Life Sciences went on to found or lead other companies.
Competitors · 5
by search overlap
Day One Biopharmaceuticals8 shared keywordsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
Korro Bio8 shared keywordsKorro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.
Precision BioSciences7 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Life Biosciences7 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan
Bridgebio6 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Companies competing with Rubedo Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Rubedo Life Sciences do?
- Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan. The company applies artificial intelligence and chemistry to drug discovery in the longevity and regenerative medicine space.
- Who are Rubedo Life Sciences's investors?
- Rubedo Life Sciences's investors include Beiersdorf Innovation Fund, CDP Venture Capital, Evolution Ventures, Khosla Ventures, LongeVC, Modi Ventures, Moonstone Venture Capital, Ahren Innovation Capital.
- How much funding has Rubedo Life Sciences raised?
- Rubedo Life Sciences has disclosed $40M raised across 1 round.